A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16)

被引：17

作者：

Platten, Michael

Schilling, Daniela

Bunse, Lukas

Wick, Antje

Bunse, Theresa

Riehl, Dennis

Karapanagiotou-Schenkel, Irini

Harting, Inga

Sahm, Felix

Schmitt, Anita

Steinbach, Joachim Peter

Weyerbrock, Astrid

Hense, Joerg

Misch, Martin

Krex, Dietmar

Stevanovic, Stefan

Tabatabai, Ghazaleh

von Deimling, Andreas

Schmitt, Michael

Wick, Wolfgang

机构：

[1] German Canc Res Ctr, Mannheim Univ Hosp, Mannheim, Germany

[2] Natl Ctr Tumor Dis, Heidelberg, Germany

[3] German Canc Res Ctr, Heidelberg, Germany

[4] Heidelberg Univ, Natl Ctr Tumor Dis, Neurol Clin, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] DKFZ, Heidelberg, Germany

[7] Heibelberg Univ Hosp, German Canc Res Ctr DKFZ, Heidelberg, Germany

[8] Univ Heidelberg Med Ctr, Dept Neuroradiol, Heidelberg, Germany

[9] Univ Heidelberg Hosp, German Canc Res Ctr DKFZ, Heidelberg, Germany

[10] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[11] Dr Senckenberg Inst Neurooncol, Frankfurt, Germany

[12] Univ Freiburg, Dept Neurosurg, Freiburg, Germany

[13] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany

[14] Univ Berlin, Charite Med Ctr, Berlin, Germany

[15] Carl Gustav Carus Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany

[16] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany

[17] Univ Hosp, Dept Neurol, Zurich, Switzerland

[18] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[19] Heidelberg Univ, Med Ctr, Heidelberg, Germany

[20] DKTK, DKFZ, Neurol Clin, Heidelberg, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.2001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2001

引用

页数：1